340 related articles for article (PubMed ID: 18202319)
1. Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells.
Johnson KA; Polewski M; Terkeltaub RA
Circ Res; 2008 Mar; 102(5):529-37. PubMed ID: 18202319
[TBL] [Abstract][Full Text] [Related]
2. A vascular bone collector: arterial calcification requires tissue-type transglutaminase.
Vanbavel E; Bakker EN
Circ Res; 2008 Mar; 102(5):507-9. PubMed ID: 18340013
[No Abstract] [Full Text] [Related]
3. Distinct transglutaminase 2-independent and transglutaminase 2-dependent pathways mediate articular chondrocyte hypertrophy.
Johnson KA; van Etten D; Nanda N; Graham RM; Terkeltaub RA
J Biol Chem; 2003 May; 278(21):18824-32. PubMed ID: 12606540
[TBL] [Abstract][Full Text] [Related]
4. Tissue Transglutaminase Modulates Vascular Stiffness and Function Through Crosslinking-Dependent and Crosslinking-Independent Functions.
Steppan J; Bergman Y; Viegas K; Armstrong D; Tan S; Wang H; Melucci S; Hori D; Park SY; Barreto SF; Isak A; Jandu S; Flavahan N; Butlin M; An SS; Avolio A; Berkowitz DE; Halushka MK; Santhanam L
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28159817
[TBL] [Abstract][Full Text] [Related]
5. Two sides of MGP null arterial disease: chondrogenic lesions dependent on transglutaminase 2 and elastin fragmentation associated with induction of adipsin.
Beazley KE; Reckard S; Nurminsky D; Lima F; Nurminskaya M
J Biol Chem; 2013 Oct; 288(43):31400-8. PubMed ID: 24036114
[TBL] [Abstract][Full Text] [Related]
6. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers.
Steitz SA; Speer MY; Curinga G; Yang HY; Haynes P; Aebersold R; Schinke T; Karsenty G; Giachelli CM
Circ Res; 2001 Dec; 89(12):1147-54. PubMed ID: 11739279
[TBL] [Abstract][Full Text] [Related]
7. The redox state of transglutaminase 2 controls arterial remodeling.
van den Akker J; VanBavel E; van Geel R; Matlung HL; Guvenc Tuna B; Janssen GM; van Veelen PA; Boelens WC; De Mey JG; Bakker EN
PLoS One; 2011; 6(8):e23067. PubMed ID: 21901120
[TBL] [Abstract][Full Text] [Related]
8. Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1-/- mice.
Johnson K; Polewski M; van Etten D; Terkeltaub R
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):686-91. PubMed ID: 15625282
[TBL] [Abstract][Full Text] [Related]
9. Transamidation by transglutaminase 2 transforms S100A11 calgranulin into a procatabolic cytokine for chondrocytes.
Cecil DL; Terkeltaub R
J Immunol; 2008 Jun; 180(12):8378-85. PubMed ID: 18523305
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice.
Kaartinen MT; Murshed M; Karsenty G; McKee MD
J Histochem Cytochem; 2007 Apr; 55(4):375-86. PubMed ID: 17189522
[TBL] [Abstract][Full Text] [Related]
11. External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification.
Johnson KA; Terkeltaub RA
J Biol Chem; 2005 Apr; 280(15):15004-12. PubMed ID: 15691824
[TBL] [Abstract][Full Text] [Related]
12. Estrogen Receptor Control of Atherosclerotic Calcification and Smooth Muscle Cell Osteogenic Differentiation.
McRobb LS; McGrath KCY; Tsatralis T; Liong EC; Tan JTM; Hughes G; Handelsman DJ; Heather AK
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1127-1137. PubMed ID: 28473445
[TBL] [Abstract][Full Text] [Related]
13. Dorsomorphin homologue 1, a highly selective small-molecule bone morphogenetic protein inhibitor, suppresses medial artery calcification.
Lin T; Wang XL; Zettervall SL; Cai Y; Guzman RJ
J Vasc Surg; 2017 Aug; 66(2):586-593. PubMed ID: 27374065
[TBL] [Abstract][Full Text] [Related]
14. A vascular smooth muscle cell X-box binding protein 1 and transglutaminase 2 regulatory circuit limits neointimal hyperplasia.
Serrano RL; Yu W; Graham RM; Bryan RL; Terkeltaub R
PLoS One; 2019; 14(4):e0212235. PubMed ID: 30943188
[TBL] [Abstract][Full Text] [Related]
15. The integrin alpha5beta1 regulates chondrocyte hypertrophic differentiation induced by GTP-bound transglutaminase 2.
Tanaka K; Yokosaki Y; Higashikawa F; Saito Y; Eboshida A; Ochi M
Matrix Biol; 2007 Jul; 26(6):409-18. PubMed ID: 17490870
[TBL] [Abstract][Full Text] [Related]
16. Transglutaminase 2 promotes PDGF-mediated activation of PDGFR/Akt1 and β-catenin signaling in vascular smooth muscle cells and supports neointima formation.
Nurminskaya M; Beazley KE; Smith EP; Belkin AM
J Vasc Res; 2014; 51(6):418-28. PubMed ID: 25612735
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminase inhibitors attenuate vascular calcification in a preclinical model.
Beazley KE; Banyard D; Lima F; Deasey SC; Nurminsky DI; Konoplyannikov M; Nurminskaya MV
Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):43-51. PubMed ID: 23117658
[TBL] [Abstract][Full Text] [Related]
18. Extracellular transglutaminase 2 activates beta-catenin signaling in calcifying vascular smooth muscle cells.
Faverman L; Mikhaylova L; Malmquist J; Nurminskaya M
FEBS Lett; 2008 Apr; 582(10):1552-7. PubMed ID: 18405667
[TBL] [Abstract][Full Text] [Related]
19. Leukocyte transglutaminase 2 expression limits atherosclerotic lesion size.
Boisvert WA; Rose DM; Boullier A; Quehenberger O; Sydlaske A; Johnson KA; Curtiss LK; Terkeltaub R
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):563-9. PubMed ID: 16410462
[TBL] [Abstract][Full Text] [Related]
20. Transglutaminase activity is decreased in large arteries from hypertensive rats compared with normotensive controls.
Petersen-Jones HG; Johnson KB; Hitomi K; Tykocki NR; Thompson JM; Watts SW
Am J Physiol Heart Circ Physiol; 2015 Mar; 308(6):H592-602. PubMed ID: 25599570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
